Spiral Therapeutics Receives Hearing Technology Innovator Award
SOUTH SAN FRANCISCO, Calif., August 30, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced today that it has been recognized for its innovative Drug Delivery Platform in the fourth annual Hearing Technology Innovator Awards™. The annual awards program by Hearing Health & Technology Matters (HHTM) acknowledges technological innovation and […]
Spiral Therapeutics Announces CEO’s Participation at the 3rd Inner Ear Disorders Therapeutics Summit in Boston, MA
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, is proud to announce the participation of its Chief Executive Officer, Hugo Peris, at the forthcoming 3rd Inner Ear Disorders Therapeutics Summit. The event is scheduled to take place from August 29-31, 2023, in […]
Spiral Therapeutics Announces SPT-2101 Presentation at the 15th ASOHNS Congress in Brisbane, Australia
SOUTH SAN FRANCISCO, Calif., Mar. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming 15th Asia Oceania ORL-HNS Congress, to be held March 8-12, 2023 in Brisbane, Australia. Dr. Jafri Kuthubutheen will join the session “Vestibular: Surgical vertigo” for an oral […]